Table 2 High-risk (HR) HPV positivity overall and for types 16 and 18 for different tests (ordered by overall high-risk HPV positivity)

From: Comparing the performance of six human papillomavirus tests in a screening population

Test

Number tested

Number adequate result

Positive (%)

HPV 16 positive (%)

HPV 18 positive (%)

Other HR HPV positive (%)

BD HPV

5998

5965

970 (16.3)

168 (2.8)

71 (1.2)

834 (14.0)

Roche Cobas

5986

5979

959 (16.0)

211 (3.5)

86 (1.4)

801 (13.4)

Qiagen Hybrid Capture 2

5984

5984

906 (15.1)

—

—

—

Abbott RealTime High Risk HPV

5994

5990

801 (13.4)

180 (3.0)

70 (1.2)

634 (10.6)

Gen-Probe APTIMA

6000

5995

620 (10.3)

128 (2.1)

63 (1.1)a

—

NorChip PreTect HPV-Proofer

5969

5747b

297 (5.2)

116 (2.0) c

51 (0.9) c

139 (2.4)d

  1. Abbreviations: HPV=human papillomavirus; HR=high risk.
  2. aTested HPV 18/45 combined.
  3. bn=76 U1A mRNA not detected, n=132 testing failed for technical reasons, n=10 failed quality control, n=4 low U1A mRNA (indeterminate result).
  4. cSamples were excluded if the overall result was inadequate.
  5. Includes only types 31, 33 and 45.
Back to article page